[1] |
SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing.
Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895.
|
[2] |
ZHONG Hong, CHEN Hong, ZHANG Xuanyi, DENG Huiyuan, LUO Xianglin, WAN Jie, KONG Wenqiang.
Detection and analysis of signals of adverse events induced by deferasirox based on FAERS
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 931-935.
|
[3] |
WEN Hairuo, HUANG Qin, HAN Suqin, JIANG Hua, QIN Chao, SHI Haokun, ZHAO Tingting, GENG Xingchao, WANG Qi.
Mutagenicity risk of N-nitrosobumetanil in SD rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 307-312.
|
[4] |
HUANG Huanjun, MAI Jiaheng, ZHANG Yunhui, GUO Chenchen, LIANG Weiting.
Adverse drug reaction induced by antineoplastic drugs in a cancer hospital: an analysis of 613 cases
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(3): 324-328.
|
[5] |
ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie.
Adverse reaction monitoring of toothpaste in China under the new regulatory system
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222.
|
[6] |
LIU Meiting, MENG Jing, TIAN Jingzhuo, ZHAO Yong, YI Yan, LI Chunying, LIU Chenyue, CUI Shuang, ZHANG Yushi, WANG Lianmei, LIANG Aihua.
Effect of long-term oral administration of Asari Radix et Rhizoma decoction and its main aristolochic acid analogs to mice main organs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1087-1094.
|
[7] |
YANG Minghan, QIAO Meiling, LUO Jiaoyang, YANG Meihua, SHENG Ping.
Acute toxicity of anti-gastric cancer active ingredients of Ferula ferulaeoides
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 880-884.
|
[8] |
SHEN Ningning, LIU Yufu, RU Yi, SHI Zhuo, YANG Chunqi, NI Zhexin, XIAO Chengrong, MA Zengchun, WANG Yuguang, GAO Yue.
Antifatigue effect of ophiopogonin D on exhaustive swimming in mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 749-753.
|
[9] |
WANG Rong, LIU Ziqun, WANG Nana, TAN Xiong, ZHANG Yixin, YANG Kuan, QIN Bei.
Acute toxicity of proline Danshensu borneol ester in mice
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 754-757.
|
[10] |
ZUO Zeping, TIAN Yingying, XU Yi, JIANG Kewu, YANG Shuo, YANG Hairun, ZHANG Zhicong, CAO Xinyao, WU Xiaoru, WANG Zhibin.
Preclinical safety evaluation of Jinkui Shenqi pills
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 775-782.
|
[11] |
ZHU Lan, JIN Zhe, LIU Lihong, ZHONG Lumiao, LIUXiaojun.
Risks of Kangfuxiaoyan suppository due to routes of administration
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(3): 306-310.
|
[12] |
LI Meiyun, TANG Guangliang, CHEN Zhihong, HE Xin, CHEN Shenjue, LI Xin, LIU Lihua.
Analysis of 107 reports of ADR induced by ribavirin
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 770-774.
|
[13] |
WANG Zhonglan, WANG Yu, HAO Lina, HU Lihua, WANG Xiaoling, ZHAO Zhigang.
Taking wrong medicines by children and precautions
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 779-781.
|
[14] |
ZHENG Chengcheng, WANG Huiping, XU Baihui, XU Jiaoyan, LI Beibei, ZHANG Xiaohong, ZHANG Wei, SUN Ying, WANG Enli.
Toxicity of Jingfang granule extract on embryo-fetal developmental of rats
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 493-497.
|
[15] |
ZHENG Chengcheng, XU Baihui, XU Jiaoyan, WANG Huiping, LI Beibei, ZHANG Xiaohong, SUN Ying, YAO Jingchun, WANG Enli.
Toxicity of Jingfang granule extract on perinatal rats
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(5): 498-504.
|